Regulatory 2019-11-14 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 14 November 2019 PDF Report Presentation Webcast
2019-11-08 | Preparations for Phase III study with Mangoral[®] on track PDF Report Presentation Webcast
Regulatory 2019-10-14 | Notice of Annual General Meeting of Ascelia Pharma AB PDF Report Presentation Webcast
2019-09-11 | Ascelia Pharma to present at Redeye seminar in Malmö on 12 September 2019 PDF Report Presentation Webcast
2019-09-06 | Ascelia Pharma to present at Share Day (Aktiedagen) in Stockholm on 10 September 2019 PDF Report Presentation Webcast
2019-08-20 | Invitation to presentation of Ascelia Pharma’s Q4 report 2018/2019 PDF Report Presentation Webcast
Regulatory 2019-06-10 | Ascelia Pharma strengthens its Mangoral franchise by filing of a patent application for next generation Mangoral product PDF Report Presentation Webcast
2019-05-20 | Ascelia Pharma to present at Avanza börsdag, 22 May 2019 PDF Report Presentation Webcast
2019-05-15 | Fully financed Phase III program for Mangoral through the IPO PDF Report Presentation Webcast
2019-05-13 | Ascelia Pharma to host teleconference for presentation of interim financial report PDF Report Presentation Webcast
Regulatory 2019-05-10 | Nomination Committee appointed for AGM 2019 in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2019-05-07 | Ascelia Pharma received supportive feedback from EMA on the phase 3 program for Mangoral® PDF Report Presentation Webcast
Regulatory 2019-04-08 | Encouraging results from the Phase I combination study with Oncoral and oral capecitabine published in the journal Cancer Chemotherapy and Pharmacology PDF Report Presentation Webcast
2018-11-19 | Ascelia Pharma receives positive feedback from FDA on design of the pivotal Phase 3 study with Mangoral® PDF Report Presentation Webcast
2018-11-13 | Encouraging results from clinical Phase I study of Oncoral presented in a new publication PDF Report Presentation Webcast
2018-10-23 | Oncoral demonstrates encouraging results in clinical phase I PDF Report Presentation Webcast
Regulatory 2018-09-14 | Carl Bjartmar appointed as new Chief Medical Officer for Ascelia Pharma PDF Report Presentation Webcast
